Rchr
J-GLOBAL ID：201601005186225169
Update date: Mar. 04, 2026
Shingai Masashi
シンガイ マサシ | Shingai Masashi
Affiliation and department：
Job title：
Associate Professor
Research field (2)：
Molecular biology
, Molecular biology
Research keywords (5)：
antibody
, Vaccine
, Measles
, HIV
, Influenza virus
Research theme for competitive and other funds (2)：
- 2018 - 2021 Investigation of the mechanism of inducing the original antigenic sin phenomenon associated with influenza virus infection
- 2006 - 2007 麻疹ウイルス感染モデルを用いた樹状細胞からの麻疹ウイルス免疫抑制機構の解明
Papers (67)：
-
Yuriko Takagi, Tasuku Nishimura, Suraiya Aktar, Daisuke Katayama, Ken Takashima, Tomomi Kawakita, Toshiki Sekiya, Masashi Shingai, Hiroki Tanaka, Hidetaka Akita, et al. Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice. Molecular therapy. Nucleic acids. 2026. 37. 1. 102784-102784
-
Yasutake Yanagihara, Toshiyuki Masuzawa, Masashi Shingai, Marumi Ohno, Toshiki Sekiya, Naoki Nomura, Tomomi Kawakita, Chimuka Handabile, Yuichi Koshiishi, Richard Obeng-Kyeremeh, et al. A Case of Infection with Leptospires from Three Different Serovars During a Flood in the Philippines. The American journal of tropical medicine and hygiene. 2025
-
Akari Yamaya, Kento Sonoda, Tomomi Kawakita, Yuichi Koshiishi, Masashi Shingai, Misako Matsumoto, Tsukasa Seya. ARNAX, but not conventional adjuvants, alum and squalene, induces antigen-specific CD8+ T cell proliferation in vaccination with influenza split vaccine. International immunopharmacology. 2025. 159. 114895-114895
-
Marumi Ohno, Toshiki Sekiya, Richard Obeng-Kyeremeh, Chimuka Handabile, Minori Haruta, Naoki Nomura, Tomomi Kawakita, Masashi Shingai, Hiroshi Kida. Optimization of the preparation method of inactivated intact virus particle vaccine for COVID-19. Vaccine. 2025. 56. 127173-127173
-
Tomomi Kawakita, Toshiki Sekiya, Yayoi Kameda, Naoki Nomura, Marumi Ohno, Chimuka Handabile, Akari Yamaya, Hideo Fukuhara, Yuki Anraku, Shunsuke Kita, et al. ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction. Journal of virology. 2025. e0229024
ｍore...
MISC (6)：
-
小林颯太, 関屋俊輝, 喜多俊介, 新開大史, 喜田宏, 前仲勝実, 前仲勝実, 前仲勝実, 前仲勝実. Single particle analysis of A/Singapore/GP1908/2015 (H1N1) influenza virus hemagglutinin. 日本生体防御学会学術総会講演抄録集. 2024. 35th (Web)
-
野村直樹, 新開大史, 松野啓太, 関屋俊輝, 関屋俊輝, 大野円実, 磯田典和, 迫田義博, 喜田宏, 喜田宏. インフルエンザウイルスライブラリーを活用したパンデミックインフルエンザ対策. 日本獣医学会学術集会講演要旨集. 2021. 164th (CD-ROM)
-
新開大史, 新開大史, 野村直樹, 関屋俊輝, 関屋俊輝, 大野円実, 笹田万友美, 大東卓史, 鈴木紗織, 石垣宏仁, et al. 不活化インフルエンザウイルス全粒子ワクチンの非臨床試験. 日本ワクチン学会学術集会プログラム・抄録集. 2018. 22nd
-
伊藤靖, 鈴木紗織, 石垣宏仁, 仲山美沙子, 新開大史, 新開大史, 大東卓史, 野村直樹, 喜田宏, 喜田宏, et al. サルモデルを用いた季節性インフルエンザに対する不活化全粒子ワクチンの有効性評価. 日本ワクチン学会学術集会プログラム・抄録集. 2018. 22nd
-
SHINGAI Masashi, MATSUMOTO Misako, SEYA Tsukasa. "Innate barrier" among species on viral infection : Role of Type-I IFN in establishment of measles virus systemic infection. 2007. 35. 1. 21-29
ｍore...
Professional career (1)：
- PhD (Osaka city university)
Return to Previous Page
